StonvexLoading…
StonvexStonvexStonvexCore line items from CI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-29 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $72.41B | $68.49B | $274.90B | $202.43B | $132.68B |
Operating Income | Not available | $2.36B | $9.20B | $6.86B | $4.28B |
Net Income | Not available | $1.65B | $5.96B | $5.01B | $3.04B |
EPS (Diluted) | $7.77 | $6.26 | $22.18 | $17.52 | $10.55 |
Total Assets | Not available | $153.27B | $157.92B | $157.92B | $151.65B |
Total Liabilities | Not available | $110.82B | $116.05B | $115.91B | $111.22B |
Cash & Equivalents | Not available | $7.04B | $7.68B | $6.03B | $4.33B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 264.02M | 263.46M | 269.53M | 270.54M |